Assessment of Microalbuminuria with glycosylated haemoglobin (HbA1c) among type 2 diabetic patients

Background: The present study aimed to assess the relationship between Microalbuminuria and HbA1c among type 2 DM patients. Materials and methods: In the present study, 50 type 2 diabetic subjects and 50 healthy non-diabetic subjects were investigated for fasting blood sugar (FBG), and glycosylated hemoglobin (HbA1c), and urinary microalbuminuria (24hr) Results: The mean ± SDs of FBG, HbA1c, and urinary microalbumin, in controls, were in the range of 93.30 ± 10.09, 4.80 ± 0.192, and 25.14 ± 3.55, respectively. It is observed that the mean ± SDs of FBG, HbA1c, and urinary microalbumin, in cases, were in the range of 174.80 ± 9.57, 7.81 ± 1.58, and 120.7 ± 1.58, respectively. It was evident that FBG, HbA1c, and urinary microalbumin levels were increased in cases as compared to controls. The mean ± SD level of FBG, HbA1c, and urinary microalbumin were statistically significantly increased in diabetic cases compared to non-diabetic controls (P<0.0001). Conclusion: The present study concludes that poor glycemic control among type 2 DM patients may lead to the development of microalbuminuria, which in turn brings about changes resulting in progressive renal diseases. The situation can be averted by maintaining good glycemic control and adopting a healthy lifestyle. The study recommends regular screening of HbA1c, microalbuminuria among type 2 diabetic patients for identification and timely management of patients at risk.